April 2022
CNS Drugs Take 20% Longer to Develop and to Approve vs. Non-CNS Drugs
Central Nervous System Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Report Linker (April 22, 2022). Access article
Over 10,000 Diseases And Only 50 Drugs Approved In 2021. To Improve Pharma R&D Efficiency We Need To Understand It.
Over 10,000 Diseases And Only 50 Drugs Approved In 2021. To Improve Pharma R&D Efficiency We Need To Understand It.
Forbes (April 11, 2022). Access article
The Incidence of Protocol Deviations and Amendments is High and Rising
Why clinical trials need expert support for ongoing success
Clinical Trials Arena (April 6, 2022). Access article
March 2022
Tufts CSDD Study on Staff Diversity in Global Investigative Sites
Restoring trust in clinical trials among Black communities
MedCity News (March 18, 2022). Access article
Measuring Patient Satisfaction as a Primary Outcome for Patient-Centric Initiatives
Measuring Patient Satisfaction as a Primary Outcome for Patient-Centric Initiatives
Applied Clinical Trials (March 17, 2022). Access article
Rising Protocol Design Complexity Is Driving Rapid Growth in Clinical Trial Data Volume
eClinical Solutions Drives Strong Annual Growth Marked by New Products, Employee Hirings, and Expansion in West Coast and European Life Science Markets
Business Wire (March 10, 2022). Access article
February 2022
Assessing the Impact of DCT on Outsourced Relationships
Characterizing the Process of Adopting Innovations Supporting Drug Development Operations
Applied Clinical Trials (February 7, 2022). Access article
January 2022
Protocol Complexity and Patient Enrollment Intensify Challenges in Oncology Trials
No End in Sight for Trial Complexity, CSDD Report Reveals
CenterWatch (January 17, 2022). Access article
Assessing the Impact of DCT on Outsourced Relationships
Tufts links decentralized clinical trials to shorter cycle times, cost savings
Outsourcing Pharma (January 28, 2022). Access article
Decentralized clinical trials can achieve net financial benefits 5 to 14 times
The Health Guild (January 13, 2022). Access article
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Business Wire (January 13, 2022). Access article
Not just for a pandemic: Decentralized clinical trials pay off financially, study finds
Fierce Biotech (January 12, 2022). Access article
Latest financial model shows substantial net benefits for sponsors that use DCTs
Medable (January 12, 2022). Download White Paper
The Incidence of Protocol Deviations and Amendments in Trials is High and Rising
Trial by fire: More study protocols are experiencing substantial — and costly — changes
StatNews (January 10, 2022). Access article
December 2021
New Study Finds Site Personnel Race and Ethnicity Highly Correlated with Diversity of Patients Enrollment - Press Release
To Increase Diversity in Clinical Trials, First Increase Staff Diversity
TuftsNow (December 3, 2021). Access article
November 2021
New Study Finds Site Personnel Race and Ethnicity Highly Correlated with Diversity of Patients Enrollment - Press Release
Dedicated Sites, Private Practices Outdoing AMCs on Diversity Front
CenterWatch (November 15, 2021). Access article
Clinical trial sites face challenges in diversifying personnel and participants, study finds
StatNews (November 5, 2021). Access article
Race, ethnicity of trial patients 'highly correlated' with staff of site investigators: study
FierceBiotech (November 3, 2021). Access article
Diversity of Site Staff Highly Associated with Diversity of Patients Enrolled Trials, According to Tufts
Applied Clinical Trials (November 2, 2021). Access article